# Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

> **NCT04779047** · PHASE4 · UNKNOWN · sponsor: **October 6 University** · enrollment: 150 (estimated)

## Conditions studied

- Covid19
- Pneumonia

## Interventions

- **DRUG:** Remdesivir
- **DRUG:** Hydroxychloroquine
- **DRUG:** Tocilizumab
- **DRUG:** Lopinavir/ Ritonavir
- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04779047
- **Lead sponsor:** October 6 University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-04-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04779047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04779047, "Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04779047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*